Your Article Summary
See Latest ArticlesS-1 monotherapy in patients with advanced biliary tract cancer
Oncology (Karger), 06/30/09
Sasaki T et al. - In a trial to evaluate the efficacy and safety of single-agent S-1 in pts with advanced biliary tract cancer, it was reported that S-1 monotherapy is a feasible and moderately efficacious treatment for advanced biliary tract cancer, as a first- or second-line chemotherapy regimen.
Methods- S-1 was administered orally at a dose of 80 mg/m2 for 28 days, followed by 14 days of rest (1 cycle).
- Treatment was repeated until disease progression, unacceptable toxicity, or pt refusal.
- 45 pts were enrolled; among these, 29 pts received S-1 as first-line chemotherapy and 16 pts received S-1 as second-line chemotherapy.
- Response rates for first- and second-line chemotherapy were 17.2 and 18.8%, respectively.
- Median times to progression for first- and second-line chemotherapy groups were 4.2 and 5.5 mos, respectively.
- Median overall survival and 1-yr survival rate for each group were 8.7 and 8.0 mos and 42.2 and 38.2%, respectively.
- Only the first-line chemotherapy group experienced grade 3/4 toxicities, including leukopenia (6.9%), neutropenia (10.3%), anemia (6.9%), thrombocytopenia (10.3%) and total bilirubin elevation (3.4%).
Related Articles
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer
Annals of Oncology, 10/19/09
Relevance Score: 45%
Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study : The Lancet Oncology
The Lancet Oncology - Online First, 10/09/09
Relevance Score: 44%
Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study)
Annals of Oncology, 11/06/09
Relevance Score: 43%
A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity
European Journal of Surgical Oncology, 10/28/09
Relevance Score: 40%
Completely Displaced S-1/S-2 Growth Plate Fracture in an Adolescent: Case Report and Review of Literature
Journal of Orthopaedic Trauma, 10/28/09
Relevance Score: 40%
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Is temperature an effect modifier of the association between green tea intake and gastric cancer risk
European Journal of Cancer Prevention, 12/08/09
Detection of Treatment-Induced Changes in Signaling Pathways in Gastrointestinal Stromal Tumors Using Transcriptomic Data
Cancer Research, 12/08/09
Job strain and risk of esophageal and cardia cancers
Cancer Epidemiology, 12/08/09
Today in Hepatobiliary/Pancreas...keeping you current
Receive free subspecialty "5-minute updates" via email
An oxidative analogue of gambogic acid-induced apoptosis of human hepatocellular carcinoma cell line HepG2 is involved in its anticancer activity in vitro
European Journal of Cancer Prevention, 12/08/09
Autophagy Is Activated by TGF-beta and Potentiates TGF-beta–Mediated Growth Inhibition in Human Hepatocellular Carcinoma Cells
Cancer Research, 12/08/09
Obesity and liver cancer mortality in Asia: The Asia Pacific Cohort Studies Collaboration
Cancer Epidemiology, 12/08/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of functional electrical stimulation on dysphagia caused by radiation therapy in patients with nasopharyngeal carcinoma
Supportive Care in Cancer, 12/08/09
Is there a role for intensifying induction therapy in acute myeloid leukaemia (AML)?
Best Practice & Research: Clinical Haematology , 12/08/09
Tailoring iron chelation by iron intake and serum ferritin: prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias
Haematologica, 12/08/09